Predictive Factors for Response and Progression after Treatment with Rituximab in Previously Untreated Patients with Waldenstrom's Macroglobulinemia (WM).
Predictive Factors for Response and Progression after Treatment with Rituximab in Previously Untreated Patients with Waldenstrom's Macroglobulinemia (WM).
Languages of Item:
English
Abstract:
Empty abstract
Publication year:
2005
Authors:
Anagnostopoulos, Athanasios Treon, Steven P Zervas, Konstantinos Branagan, Andrew Gika, Dimitra Zomas, Athanasios Kyrtsonis, Marie Christine Vassou, Amalia Anagnostopoulos, Nikolaos Pangalis, Gerasimos others
